Bank of New York Mellon
JBIO

Bank of New York Mellon’s Jade Biosciences JBIO Stock Holding History

Bank of New York Mellon’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Sell
85,343
-4,621
-5% -$96.4K ﹤0.01% 2981
2026
Q1 		$1.26M Sell
89,964
-24,942
-22% -$361K ﹤0.01% 3075
2025
Q4 		$1.77M Buy
114,906
+32,555
+40% +$382K ﹤0.01% 2908
2025
Q3 		$711K Buy
82,351
+3,958
+5% +$32.3K ﹤0.01% 3402
2025
Q2 		$783K Buy
78,393
+77,349
+7,409% +$2.63M ﹤0.01% 3257
2025
Q1 		$91.7K Sell
1,044
-32
-3% -$2.81K ﹤0.01% 4010
2024
Q4 		$99.8K Sell
1,076
-109
-9% -$9.39K ﹤0.01% 4034
2024
Q3 		$86.7K Sell
1,185
-158
-12% -$10.2K ﹤0.01% 4021
2024
Q2 		$78K Buy
1,343
+553
+70% +$367K ﹤0.01% 4043
2024
Q1 		$818K Sell
790
-255
-24% -$195K ﹤0.01% 3257
2023
Q4 		$827K Buy
1,045
+262
+33% +$134K ﹤0.01% 3288
2023
Q3 		$372K Buy
783
+5
+0.6% +$2.71K ﹤0.01% 3704
2023
Q2 		$467K Sell
778
-16
-2% -$10.2K ﹤0.01% 3638
2023
Q1 		$561K Sell
794
-9
-1% -$7.46K ﹤0.01% 3437
2022
Q4 		$823K Buy
803
+16
+2% +$11.6K ﹤0.01% 3293
2022
Q3 		$457K Buy
787
+71
+10% +$47.4K ﹤0.01% 3610
2022
Q2 		$392K Sell
716
-155
-18% -$74K ﹤0.01% 3735
2022
Q1 		$559K Buy
871
+191
+28% +$74.1K ﹤0.01% 3642
2021
Q4 		$281K Buy
680
+57
+9% +$28.8K ﹤0.01% 4125
2021
Q3 		$457K Buy
+623
New +$349K ﹤0.01% 3863

Other funds holding JBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bank of New York Mellon's JBIO Position: Q2 2026 in Review

Bank of New York Mellon reduced its Jade Biosciences (JBIO) stake by 5.1% in Q2 2026, selling an estimated $96.4K and leaving 85,343 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

Bank of New York Mellon first reported a position in JBIO in Q3 2021 and has held it in 20 quarters since. 63 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Bank of New York Mellon held 85,343 shares of Jade Biosciences worth $1.9M as of Q2 2026.
  • Bank of New York Mellon sold 4,621 Jade Biosciences shares in Q2 2026, an estimated $96.4K.
  • Jade Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2981 holding.
  • Bank of New York Mellon first reported a position in Jade Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 63 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.